HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo (Q40502658)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo |
scientific article |
Statements
1 reference
HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo (English)
1 reference
Takayuki Ikezoe
1 reference
Yasuko Hisatake
1 reference
Tamotsu Takeuchi
1 reference
Yuji Ohtsuki
1 reference
Yang Yang
1 reference
Jonathan W Said
1 reference
Hirokuni Taguchi
1 reference
H Phillip Koeffler
1 reference
1 October 2004
1 reference
1 reference
64
1 reference
20
1 reference
7426-7431
1 reference
Identifiers
1 reference
1 reference